You could be reading the full-text of this article now if you...

If you have access to this article through your institution,
you can view this article in

In-vitro melanoma models: invasive growth is determined by dermal matrix and basement membrane

Commandeur, Suzan; Sparks, Sarah J.; Chan, Hee-Lam; Gao, Linda; Out, Jacoba J.; Gruis, Nelleke A.; van Doorn, Remco; el Ghalbzouri, Abdoelwaheb

Melanoma Research:
doi: 10.1097/CMR.0000000000000079
ORIGINAL ARTICLES: Basic research
Abstract

A critical first step in the metastatic progression of cutaneous melanoma, invasive growth into the dermal compartment, would ideally be studied in the proper three-dimensional tissue microenvironment. In this study, we compared the growth and behavior of four melanoma cell lines originating from primary and metastatic human cutaneous melanomas (AN, RU, M14, and WK) in in-vitro human skin equivalents (HSEs) generated with four different dermal matrices: human fibroblast-seeded rat tail collagen, human fibroblast-derived matrix (FDM), noncellular human de-epidermized dermis (DED), and a novel fully cellular human DED with an intact pre-existent basement membrane. Melanoma cells showed proliferation in all HSEs, indicating that the microenvironment formed in all HSEs studied here allows the growth of melanoma cells in concert with epidermal keratinocytes for multiple weeks in vitro. Melanoma cells did not affect epidermal proliferation and terminal differentiation. Growth of melanoma cells in the dermal compartment, as a measure of invasive potential, differs markedly between the four types of in-vitro human melanoma models. Notably, the growth of melanoma cells in the dermal matrix was observed in all HSEs cultured with cell lines originating from metastatic melanoma, except for cDED-based HSEs, and the growth of melanoma cells of nonmetastatic origin was observed in the dermal compartment of FDM-based HSEs. Our results show that the type of dermal equivalent and the presence of an intact basement membrane should be taken into consideration when studying melanoma invasion using in-vitro HSEs.

Author Information

Department of Dermatology, Leiden University Medical Center, Leiden, The Netherlands

Correspondence to Suzan Commandeur, PhD, Department of Dermatology, Leiden University Medical Center, Postal zone S2-P, Einthovenweg 20, 2333 ZC Leiden, The Netherlands Tel: +31 71 332 2296; fax: +31 71 332 2281; e-mail: s.commandeur@lumc.nl

Received January 6, 2014

Accepted March 4, 2014

© 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins